Ozanimod and Buprenorphine: Interaction Details

Brand names
Buprenorphine
ButransBelbucaSublocade +2 more
Ozanimod
ZeposiaZEPOSIA 7-Day Starter Pack
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Buprenorphine

Brand names
  • Butrans
  • Belbuca
  • Sublocade
  • Buprenex
  • Brixadi

Ozanimod

Brand names
  • Zeposia
  • ZEPOSIA 7-Day Starter Pack

What Happens When You Take Ozanimod With Buprenorphine

What can happen when they are taken together (rated Major)

An increased risk of or -related toxicity, an increased risk of serious adverse reactions and effects on heart rate

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Buprenorphine should not be given together with , nor within 14 days after an has been taken, because of a heightened risk of serotonin syndrome and opioid toxicity.2 In vitro, an active of ozanimod inhibits MAO-B, so serious adverse reactions are possible when ozanimod is combined with drugs that can raise norepinephrine or levels (for example, opioid drugs).

Using opioids together with MAOIs, selective MAO-B included, has precipitated serious and at times fatal adverse reactions. Ozanimod can also cause a transient reduction in heart rate and delays in atrioventricular conduction.

It has not been studied in patients receiving QT-prolonging drugs. Since additive effects on heart rate are possible, ozanimod generally should not be started in patients already treated with QT-prolonging drugs known to have arrhythmogenic properties. When such cannot be avoided, advice from a cardiologist should be sought.1

The Ozanimod and Buprenorphine Interaction, Explained

Taking buprenorphine with ozanimod may raise the risk of serious side effects. A byproduct of ozanimod (a medicine for multiple sclerosis or ulcerative colitis) can block an enzyme called MAO-B in lab studies. Medicines that do this, when combined with like buprenorphine, have sometimes caused (agitation, sweating, shaking, fast heartbeat, fever) or opioid overdose-type effects such as extreme drowsiness and slow breathing. Ozanimod can also slow the heart rate a little, especially early on. This concern is mostly theoretical so far, but it is taken seriously.

Please don't stop or change either medicine on your own. Tell your pharmacist and prescriber you take both, and they can manage this with careful planning and closer monitoring. Get urgent help if you notice the symptoms above.

Mechanism: An active ozanimod inhibits MAO-B in vitro. with or noradrenergic activity given with (including selective MAO-B ) have precipitated serious, sometimes fatal reactions (, opioid toxicity). Ozanimod may also cause transient and AV conduction delay, which is a possible heart rate effect.

  • Evidence: theoretical (in vitro MAO-B data, class labeling); onset unspecified.
  • Severity: major.
  • Management: or buprenorphine within 14 days of an is not recommended. Avoid starting ozanimod with QT-prolonging, arrhythmogenic drugs (not studied). If coadministration is unavoidable, seek cardiology advice, monitor for toxicity, /, and heart rate/.

See the 2 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Ozanimod and Buprenorphine Interact

The likely mechanism

; MAO-B and additive effects on heart rate

In short: Ozanimod and buprenorphine both raise serotonin activity, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Ozanimod and Buprenorphine Interaction

Your care team will usually try to avoid this combination, or if both are truly needed, plan it carefully and watch you more closely.

  • Keep taking both exactly as prescribed until your prescriber or pharmacist tells you otherwise.
  • Make sure every prescriber knows you use both medicines, including any recent use (within 14 days).
  • Your team may involve a heart specialist (cardiologist) and may monitor your heart rate and rhythm more closely.
  • Ask about warning signs: agitation, tremor, sweating, fever, fast or slow heartbeat, severe drowsiness, or slow breathing. Seek urgent care if they occur.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Ozanimod or Buprenorphine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Ozanimod and Buprenorphine: Common Questions

How serious is the Ozanimod and Buprenorphine interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Ozanimod and Buprenorphine interaction managed?

Your care team will usually try to avoid this combination, or if both are truly needed, plan it carefully and watch you more closely. Keep taking both exactly as prescribed until your prescriber or pharmacist tells you otherwise. Make sure every prescriber knows you use both medicines, including any recent use (within 14 days). Your team may involve a heart specialist (cardiologist) and may m… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Ozanimod and Buprenorphine Interaction

Ask in your own words about taking Ozanimod and Buprenorphine together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (2)

  1. Product Information: ZEPOSIA(R) oral capsules, ozanimod oral capsules. Bristol-Myers Squibb Company (per FDA), Princeton, NJ, 2024. DailyMed
  2. Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
Was this write-up helpful?

Other Serious Interactions of Ozanimod and Buprenorphine

Also serious with Buprenorphine

Also serious with Ozanimod

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Buprenorphine

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.